Latest Insider Transactions at Neurocrine Biosciences Inc (NBIX)
This section provides a real-time view of insider transactions for Neurocrine Biosciences Inc (NBIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NEUROCRINE BIOSCIENCES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NEUROCRINE BIOSCIENCES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 06
2023
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,830
+26.86%
|
$895,690
$43.24 P/Share
|
|
Dec 01
2023
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
5,000
-2.4%
|
$580,000
$116.77 P/Share
|
|
Dec 01
2023
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.34%
|
$60,000
$12.98 P/Share
|
|
Nov 29
2023
|
Jude Onyia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,331
-16.58%
|
$263,403
$113.57 P/Share
|
|
Nov 27
2023
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,919
-23.33%
|
$1,222,928
$112.27 P/Share
|
|
Nov 16
2023
|
Stephen A Sherwin Director |
SELL
Bona fide gift
|
Direct |
2,750
-10.98%
|
-
|
|
Oct 02
2023
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
1,437
-22.7%
|
$160,944
$112.68 P/Share
|
|
Sep 12
2023
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
5,000
-2.4%
|
$575,000
$115.02 P/Share
|
|
Sep 12
2023
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.34%
|
$60,000
$12.98 P/Share
|
|
Sep 01
2023
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
5,000
-2.4%
|
$550,000
$110.06 P/Share
|
|
Sep 01
2023
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.34%
|
$60,000
$12.98 P/Share
|
|
Sep 01
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
824
-4.56%
|
$90,640
$110.93 P/Share
|
|
Aug 30
2023
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
2,733
-25.13%
|
$292,431
$107.56 P/Share
|
|
Aug 30
2023
|
Darin Lippoldt Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
190
-0.4%
|
-
|
|
Aug 28
2023
|
Ingrid Delaet Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
1,431
-19.44%
|
$153,117
$107.52 P/Share
|
|
Aug 21
2023
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,198
-9.77%
|
$342,186
$107.38 P/Share
|
|
Aug 21
2023
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,132
-4.34%
|
$228,124
$107.39 P/Share
|
|
Aug 21
2023
|
Jude Onyia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,198
-24.91%
|
$342,186
$107.37 P/Share
|
|
Aug 21
2023
|
Ingrid Delaet Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
1,404
-23.21%
|
$150,228
$107.42 P/Share
|
|
Aug 21
2023
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,132
-1.61%
|
$228,124
$107.41 P/Share
|
|
Aug 21
2023
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,328
-1.83%
|
$998,096
$107.4 P/Share
|
|
Aug 21
2023
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
1,600
-20.53%
|
$171,200
$107.41 P/Share
|
|
Aug 21
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,132
-10.54%
|
$228,124
$107.41 P/Share
|
|
Aug 21
2023
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,132
-7.29%
|
$228,124
$107.39 P/Share
|
|
Aug 21
2023
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,600
-4.21%
|
$171,200
$107.4 P/Share
|
|
May 01
2023
|
William H Rastetter Director |
SELL
Open market or private sale
|
Direct |
4,300
-9.13%
|
$434,300
$101.43 P/Share
|
|
May 01
2023
|
William H Rastetter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,625
+13.94%
|
$91,500
$12.71 P/Share
|
|
May 01
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
11,397
-41.34%
|
$1,173,891
$103.89 P/Share
|
|
Apr 25
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
100
-0.36%
|
$10,300
$103.82 P/Share
|
|
Apr 24
2023
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,400
-35.08%
|
$1,483,200
$103.48 P/Share
|
|
Apr 21
2023
|
William H Rastetter Director |
SELL
Open market or private sale
|
Direct |
6,034
-13.26%
|
$633,570
$105.04 P/Share
|
|
Apr 21
2023
|
William H Rastetter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,765
+19.13%
|
$129,180
$12.71 P/Share
|
|
Apr 19
2023
|
William H Rastetter Director |
SELL
Open market or private sale
|
Direct |
903
-2.53%
|
$94,815
$105.0 P/Share
|
|
Apr 19
2023
|
William H Rastetter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,610
+4.32%
|
$19,320
$12.71 P/Share
|
|
Feb 08
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,328
-2.34%
|
$136,784
$103.82 P/Share
|
|
Feb 08
2023
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
980
-2.33%
|
$101,920
$104.16 P/Share
|
|
Feb 08
2023
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
701
-1.63%
|
$72,203
$103.83 P/Share
|
|
Feb 08
2023
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
911
-1.99%
|
$94,744
$104.08 P/Share
|
|
Feb 08
2023
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
980
-0.76%
|
$100,940
$103.99 P/Share
|
|
Feb 08
2023
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,274
-0.46%
|
$236,496
$104.3 P/Share
|
|
Feb 08
2023
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
700
-12.83%
|
$72,800
$104.11 P/Share
|
|
Feb 08
2023
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
980
-3.74%
|
$101,920
$104.19 P/Share
|
|
Feb 08
2023
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
980
-2.77%
|
$101,920
$104.12 P/Share
|
|
Feb 07
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
14,536
-13.09%
|
$1,482,672
$102.9 P/Share
|
|
Feb 07
2023
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,424
-14.77%
|
$1,471,248
$102.38 P/Share
|
|
Feb 07
2023
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
13,816
-13.37%
|
$1,409,232
$102.29 P/Share
|
|
Feb 07
2023
|
Jude Onyia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,508
-40.86%
|
$459,816
$102.3 P/Share
|
|
Feb 07
2023
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
14,323
-13.46%
|
$1,460,946
$102.33 P/Share
|
|
Feb 07
2023
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,424
-5.26%
|
$1,471,248
$102.35 P/Share
|
|
Feb 07
2023
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,730
-2.35%
|
$2,420,460
$102.37 P/Share
|